These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 24636808)

  • 1. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study.
    del Campo R; Garriga M; Pérez-Aragón A; Guallarte P; Lamas A; Máiz L; Bayón C; Roy G; Cantón R; Zamora J; Baquero F; Suárez L
    J Cyst Fibros; 2014 Dec; 13(6):716-22. PubMed ID: 24636808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotic supplementation in children with cystic fibrosis-a systematic review.
    Ananthan A; Balasubramanian H; Rao S; Patole S
    Eur J Pediatr; 2016 Oct; 175(10):1255-66. PubMed ID: 27576473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Limosilactobacillus reuteri LR-99 Supplementation on Body Mass Index, Social Communication, Fine Motor Function, and Gut Microbiome Composition in Individuals with Prader-Willi Syndrome: a Randomized Double-Blinded Placebo-Controlled Trial.
    Kong XJ; Liu K; Zhuang P; Tian R; Liu S; Clairmont C; Lin X; Sherman H; Zhu J; Wang Y; Fong M; Li A; Wang BK; Wang J; Yu Z; Shen C; Cui X; Cao H; Du T; Wan G; Cao X
    Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1508-1520. PubMed ID: 34115318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Lactobacillus reuteri NCIMB 30351 drops on symptoms of infantile functional gastrointestinal disorders and gut microbiota in early infants: Results from a randomized, placebo-controlled clinical trial.
    Tyrsin OY; Tyrsin DY; Nemenov DG; Ruzov AS; Odintsova VE; Koshechkin SI; D Amico L
    Eur J Pediatr; 2024 May; 183(5):2311-2324. PubMed ID: 38427038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Lactobacillus reuteri on pulmonary function test and growth of cystic fibrosis patients.
    Tabatabaii SA; Khanbabaee G; Sadr S; Farahbakhsh N; Modarresi SZ; Pourghasem M; Hajipour M
    J Sci Food Agric; 2024 Nov; 104(14):9056-9061. PubMed ID: 38982876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of
    Martí M; Spreckels JE; Ranasinghe PD; Wejryd E; Marchini G; Sverremark-Ekström E; Jenmalm MC; Abrahamsson T
    Cell Rep Med; 2021 Mar; 2(3):100206. PubMed ID: 33763652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crying Time and RORγ/FOXP3 Expression in Lactobacillus reuteri DSM17938-Treated Infants with Colic: A Randomized Trial.
    Savino F; Garro M; Montanari P; Galliano I; Bergallo M
    J Pediatr; 2018 Jan; 192():171-177.e1. PubMed ID: 28969887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactobacillus reuteri ATCC55730 in cystic fibrosis.
    Di Nardo G; Oliva S; Menichella A; Pistelli R; De Biase RV; Patriarchi F; Cucchiara S; Stronati L
    J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):81-6. PubMed ID: 24121143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial.
    Bruzzese E; Callegari ML; Raia V; Viscovo S; Scotto R; Ferrari S; Morelli L; Buccigrossi V; Lo Vecchio A; Ruberto E; Guarino A
    PLoS One; 2014; 9(2):e87796. PubMed ID: 24586292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics in cystic fibrosis patients: A double blind crossover placebo controlled study: Pilot study from the ESPGHAN Working Group on Pancreas/CF.
    Van Biervliet S; Hauser B; Verhulst S; Stepman H; Delanghe J; Warzee JP; Pot B; Vandewiele T; Wilschanski M
    Clin Nutr ESPEN; 2018 Oct; 27():59-65. PubMed ID: 30144894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral probiotic supplements on vaginal microbiota during pregnancy: a randomised, double-blind, placebo-controlled trial with microbiome analysis.
    Husain S; Allotey J; Drymoussi Z; Wilks M; Fernandez-Felix BM; Whiley A; Dodds J; Thangaratinam S; McCourt C; Prosdocimi EM; Wade WG; de Tejada BM; Zamora J; Khan K; Millar M
    BJOG; 2020 Jan; 127(2):275-284. PubMed ID: 30932317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Oral Probiotic
    Yang S; Reid G; Challis JRG; Gloor GB; Asztalos E; Money D; Seney S; Bocking AD
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Lactobacillus reuteri colonization on gut microbiota, inflammation, and crying time in infant colic.
    Nation ML; Dunne EM; Joseph SJ; Mensah FK; Sung V; Satzke C; Tang MLK
    Sci Rep; 2017 Nov; 7(1):15047. PubMed ID: 29118383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of orally administered probiotic Lactobacillus reuteri-containing tablets in peri-implant mucositis: a double-blind randomized controlled trial.
    Flichy-Fernández AJ; Ata-Ali J; Alegre-Domingo T; Candel-Martí E; Ata-Ali F; Palacio JR; Peñarrocha-Diago M
    J Periodontal Res; 2015 Dec; 50(6):775-85. PubMed ID: 25712760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of probiotic
    Rahayu ES; Mariyatun M; Putri Manurung NE; Hasan PN; Therdtatha P; Mishima R; Komalasari H; Mahfuzah NA; Pamungkaningtyas FH; Yoga WK; Nurfiana DA; Liwan SY; Juffrie M; Nugroho AE; Utami T
    World J Gastroenterol; 2021 Jan; 27(1):107-128. PubMed ID: 33505154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotic supplementation in systemic nickel allergy syndrome patients: study of its effects on lactic acid bacteria population and on clinical symptoms.
    Randazzo CL; Pino A; Ricciardi L; Romano C; Comito D; Arena E; Saitta S; Caggia C
    J Appl Microbiol; 2015 Jan; 118(1):202-11. PubMed ID: 25363062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial.
    Hsieh MC; Tsai WH; Jheng YP; Su SL; Wang SY; Lin CC; Chen YH; Chang WW
    Sci Rep; 2018 Nov; 8(1):16791. PubMed ID: 30429496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.
    Dommels YE; Kemperman RA; Zebregs YE; Draaisma RB; Jol A; Wolvers DA; Vaughan EE; Albers R
    Appl Environ Microbiol; 2009 Oct; 75(19):6198-204. PubMed ID: 19684171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial.
    Romani Vestman N; Chen T; Lif Holgerson P; Öhman C; Johansson I
    PLoS One; 2015; 10(5):e0125812. PubMed ID: 25946126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactobacillus reuteri derived from horse alleviates Escherichia coli-induced diarrhea by modulating gut microbiota.
    Wang D; Zeng J; Wujin C; Ullah Q; Su Z
    Microb Pathog; 2024 Mar; 188():106541. PubMed ID: 38224920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.